BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26260799)

  • 1. Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts.
    Fuller SJ; Osborne SA; Leonard SJ; Hardyman MA; Vaniotis G; Allen BG; Sugden PH; Clerk A
    Cardiovasc Res; 2015 Oct; 108(1):87-98. PubMed ID: 26260799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
    Johnson WB; Katugampola S; Able S; Napier C; Harding SE
    Life Sci; 2012 Feb; 90(9-10):328-36. PubMed ID: 22261303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation.
    Hamdani N; Krysiak J; Kreusser MM; Neef S; Dos Remedios CG; Maier LS; Krüger M; Backs J; Linke WA
    Circ Res; 2013 Feb; 112(4):664-74. PubMed ID: 23283722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease.
    Cook SA; Sugden PH; Clerk A
    J Mol Cell Cardiol; 1999 Aug; 31(8):1429-34. PubMed ID: 10423341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.
    Vagnozzi RJ; Gatto GJ; Kallander LS; Hoffman NE; Mallilankaraman K; Ballard VL; Lawhorn BG; Stoy P; Philp J; Graves AP; Naito Y; Lepore JJ; Gao E; Madesh M; Force T
    Sci Transl Med; 2013 Oct; 5(207):207ra141. PubMed ID: 24132636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
    Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
    Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes.
    Bovill E; Westaby S; Crisp A; Jacobs S; Shaw T
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):853-61. PubMed ID: 19327508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure.
    Lu B; Tigchelaar W; Ruifrok WP; van Gilst WH; de Boer RA; Silljé HH
    Eur J Heart Fail; 2012 Jan; 14(1):5-13. PubMed ID: 22143674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy.
    Wang L; Wang H; Ye J; Xu RX; Song L; Shi N; Zhang YW; Chen X; Meng XM
    Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):278-84. PubMed ID: 21314842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase.
    Pathan N; Franklin JL; Eleftherohorinou H; Wright VJ; Hemingway CA; Waddell SJ; Griffiths M; Dennis JL; Relman DA; Harding SE; Levin M
    Crit Care Med; 2011 Jul; 39(7):1692-711. PubMed ID: 21494108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired JAK2-induced activation of STAT3 in failing human myocytes.
    Cambi GE; Lucchese G; Djeokeng MM; Modesti A; Fiaschi T; Faggian G; Sani G; Modesti PA
    Mol Biosyst; 2012 Sep; 8(9):2351-9. PubMed ID: 22735740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling.
    Guo Y; Sui JY; Kim K; Zhang Z; Qu XA; Nam YJ; Willette RN; Barnett JV; Knollmann BC; Force T; Lal H
    Circulation; 2019 Nov; 140(22):1820-1833. PubMed ID: 31581792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulated contraction of neonatal rat ventricular myocytes.
    Strait JB; Samarel AM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1553-66. PubMed ID: 10900180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.